Eratex Djaja Tbk. vs Champion Pacific Indonesia Tbk. — how do they compare? Eratex Djaja Tbk. trades at Rp147 (market cap 190.41B, 3.3M 24h volume), while Champion Pacific Indonesia Tbk. trades at Rp414 (market cap 384.1B, 16.2K 24h volume). The key difference: Champion Pacific Indonesia Tbk. is far larger — about 2× Eratex Djaja Tbk.'s market cap, and Eratex Djaja Tbk. is more actively traded (3.3M versus 16.2K). Which is the better fit depends on your goals.
| ERTX | IGAR | |
|---|---|---|
Market Cap | 190.41B | 384.1B |
Volume | 3.3M | 16.2K |
Lot | 32.95K | 162 |
Turnover | 495.03M | 6.65M |
Average Price | 150.22 | 410.64 |
Value | 495.03M | 6.65M |
Indicative Equilibrium Price | 147 | 414 |
Indicative Equilibrium Volume | 424 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Eratex Djaja Tbk (the "Entity") was established in the framework of Foreign Capital Investment Law No.1, 1967 by Notarial Deed No.7 dated October 12, 1972 based on Deed prepared by Koerniatini Karim, Public Notary in Jakarta. Founded in 1972 as a joint venture company between PT Private Development Finance Company of Indonesia Ltd. and Limmen Investment Ltd., Unisouh Holding Ltd., Eastern Cotton Mills Ltd. Yarn spinning factory was built in 1973 on 17 ha of land in Probolinggo.
Read more on ERTX →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Read more on IGAR →